Stem Cell Authority Ltd
Stem Cell Authority, Ltd., a technology development company, focuses on the collection and cryogenic preservation of stem cells. It specializes in the collection and cryogenic preservation of the hematopoietic stem cells from the umbilical cord blood; and the Miracle Mesenchymal stem cells from the Wharton's jelly inside the umbilical cord of a newborn child. The company's technology enables birt… Read more
Market Cap & Net Worth: Stem Cell Authority Ltd (SCAL)
Stem Cell Authority Ltd (PINK:SCAL) has a market capitalization of $194.17K ($194.17K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #51065 globally and #15777 in its home market, demonstrating a -95.56% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Stem Cell Authority Ltd's stock price $0.00 by its total outstanding shares 970851065 (970.85 Million).
Stem Cell Authority Ltd Market Cap History: 2015 to 2025
Stem Cell Authority Ltd's market capitalization history from 2015 to 2025. Data shows growth from $97.09K to $194.17K (7.75% CAGR).
Stem Cell Authority Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Stem Cell Authority Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SCAL by Market Capitalization
Companies near Stem Cell Authority Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Stem Cell Authority Ltd by market ranking:
- HCA Holdings Inc (NYSE:HCA): Ranked #271 globally with a market cap of $77.08 Billion USD.
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1068 globally with a market cap of $18.32 Billion USD.
- Fresenius SE & Co. KGaA (PINK:FSNUF): Ranked #1139 globally with a market cap of $16.86 Billion USD.
- Brookdale Senior Living Inc (NYSE:BKDT): Ranked #1227 globally with a market cap of $15.19 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #271 | HCA Holdings Inc | NYSE:HCA | $77.08 Billion | $509.87 |
| #1068 | Tenet Healthcare Corporation | NYSE:THC | $18.32 Billion | $211.64 |
| #1139 | Fresenius SE & Co. KGaA | PINK:FSNUF | $16.86 Billion | $41.01 |
| #1227 | Brookdale Senior Living Inc | NYSE:BKDT | $15.19 Billion | $77.60 |
Stem Cell Authority Ltd Historical Marketcap From 2015 to 2025
Between 2015 and today, Stem Cell Authority Ltd's market cap moved from $97.09K to $ 194.17K, with a yearly change of 7.75%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $194.17K | -95.00% |
| 2024 | $3.88 Million | +90.48% |
| 2023 | $2.04 Million | -66.67% |
| 2022 | $6.12 Million | -66.67% |
| 2021 | $18.35 Million | -31.02% |
| 2020 | $26.60 Million | +13600.00% |
| 2018 | $194.17K | +100.00% |
| 2015 | $97.09K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Stem Cell Authority Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $194.17K USD |
| MoneyControl | $194.17K USD |
| MarketWatch | $194.17K USD |
| marketcap.company | $194.17K USD |
| Reuters | $194.17K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.